Cardiac troponins: 25 years on the stage and still improving their clinical value

References

• Katus HA, Looser S, Hallermayer K, et al. Development and in vitro characterization of a new immunoassay of cardiac troponin T. Clin Chem. 1992;38:386–393.
   PubMed Web of Science ®Google Scholar
• Bodor GS, Porter S, Landt Y, et al. Development of monoclonal antibodies for an assay of cardiac troponin-I and preliminary results in suspected cases of myocardial infarction. Clin Chem. 1992;38:2203–2214.
   PubMed Web of Science ®Google Scholar
• Cummins B, Auckland ML, Cummins P. Cardiac-specific troponin-I radioimmunoassay in the diagnosis of acute myocardial infarction. Am Heart J. 1987;113:1333–1344.
   PubMed Web of Science ®Google Scholar
• Global Health Estimates 2015: deaths by cause, age, sex, by country and by region, 2000–2015. Geneva: World Health Organization; 2016.
   Google Scholar
• Niska R, Bhuiya F, Xu J. National Hospital Ambulatory Medical Care Survey: 2007 emergency department summary. Natl Health Stat Report. 2010;6:1–31.
   Google Scholar
• Lindsell CJ, Anantharaman V, Diercks D, et al. The Internet Tracking Registry of Acute Coronary Syndromes (i*trACS): a multicenter registry of patients with suspicion of acute coronary syndromes reported using the standardized reporting guidelines for emergency department chest pain studies. Ann Emerg Med. 2006;48:666–677.
   PubMed Web of Science ®Google Scholar
• Diercks DB, Roe MT, Chen AY, et al. Prolonged emergency department stays of non-ST-segment-elevation myocardial infarction patients are associated with worse adherence to the American College of Cardiology/American Heart Association guidelines for management and increased adverse events. Ann Emerg Med. 2007;50:489–496.
   PubMed Web of Science ®Google Scholar
• Sun BC, Hsia RY, Weiss RE, et al. Effect of emergency department crowding on outcomes of admitted patients. Ann Emerg Med. 2013;61:605–611.
   PubMed Web of Science ®Google Scholar
• Biomarkers Definition Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther. 2001;69:89–95.
   PubMed Web of Science ®Google Scholar
• LaDue JS, Wroblewski F, Karmen A. Serum glutamic oxaloacetic transaminase activity in human acute transmural myocardial infarction. Science. 1954;120:497–499.
   PubMed Web of Science ®Google Scholar
• Report of the Joint International Society and Federation of Cardiology/World Health Organization task force on standardization of clinical nomenclature. Nomenclature and criteria for diagnosis of ischemic heart disease. Circulation. 1979;59:607–609.
   PubMed Web of Science ®Google Scholar
• Humphreys JE, Cummins P. Regulatory proteins of the myocardium. Atrial and ventricular tropomyosin and troponin-I in the developing and adult bovine and human heart. J Mol Cell Cardiol. 1984;16:643–657.
   PubMed Web of Science ®Google Scholar
• Cooper TA, Ordahl CP. A single troponin T gene regulated by different programs in cardiac and skeletal muscle development. Science. 1984;226:979–982.
   PubMed Web of Science ®Google Scholar
• Ricchiuti V, Voss EM, Ney A, et al. Cardiac troponin T isoforms expressed in renal diseased skeletal muscle will not cause false-positive results by the second-generation cardiac troponin T assay by Boehringer Mannheim. Clin Chem. 1998;44:1919–1924.
   PubMed Web of Science ®Google Scholar
• Jaffe AS, Vasile VC, Milone M, et al. Diseased skeletal muscle: a noncardiac source of increased circulating concentrations of cardiac troponin T. J Am Coll Cardiol. 2011;58:1819–1824.
   PubMed Web of Science ®Google Scholar
• Bates KJ, Hall EM, Fahie-Wilson MN, et al. Circulating immunoreactive cardiac troponin forms determined by gel filtration chromatography after acute myocardial infarction. Clin Chem. 2010;56:952–958.
   PubMed Web of Science ®Google Scholar
• Wijnker PJM, Murphy AM, Stienen GJM, et al. Troponin I phosphorylation in human myocardium in health and disease. Neth Heart J. 2014;22:463–469.
   PubMed Web of Science ®Google Scholar
• Labugger R, Organ L, Collier C, et al. Extensive troponin I and T modification detected in serum from patients with acute myocardial infarction. Circulation. 2000;102:1221–1226.
   PubMed Web of Science ®Google Scholar
• Wu AH, Feng YJ, Moore R, et al. Characterization of cardiac troponin subunit release into serum after acute myocardial infarction and comparison of assays for troponin T and I. American Association for Clinical Chemistry Subcommittee on cTnI Standardization. Clin Chem. 1998;44:1198–1208.
   PubMed Web of Science ®Google Scholar
• Gaze DC, Collinson PO. Multiple molecular forms of circulating cardiac troponin: analytical and clinical significance. Ann Clin Biochem. 2008;45:349–355.
   PubMed Web of Science ®Google Scholar
• Voss EM, Sharkey SW, Gernert AE, et al. Human and canine cardiac troponin T and creatine kinase-MB distribution in normal and diseased myocardium. Infarct sizing using serum profiles. Arch Pathol Lab Med. 1995;119:799–806.
   PubMed Web of Science ®Google Scholar
• Adams JE, Bodor GS, Davila-Roman VG, et al. Cardiac troponin I. A marker with high specificity for cardiac injury. Circulation. 1993;88:101–106.
   PubMed Web of Science ®Google Scholar
• Hein S, Scheffold T, Schaper J. Ischemia induces early changes to cytoskeletal and contractile proteins in diseased human myocardium. J Thorac Cardiovasc Surg. 1995;110:89–98.
   PubMed Web of Science ®Google Scholar
• Katus HA, Remppis A, Looser S, et al. Enzyme linked immuno assay of cardiac troponin T for the detection of acute myocardial infarction in patients. J Mol Cell Cardiol. 1989;21:1349–1353.
   PubMed Web of Science ®Google Scholar
• Ricchiuti V, Sharkey SW, Murakami MM, et al. Cardiac troponin I and T alterations in dog hearts with myocardial infarction: correlation with infarct size. Am J Clin Pathol. 1998;110:241–247.
   PubMed Web of Science ®Google Scholar
• Hamm CW, Ravkilde J, Gerhardt W, et al. The prognostic value of serum troponin T in unstable angina. N Engl J Med. 1992;327:146–150.
   PubMed Web of Science ®Google Scholar
• Antman E, Tanasijevic M, Thompson B, et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med. 1996;335:1342–1349.
   PubMed Web of Science ®Google Scholar
• Alpert JS, Thygesen K, Antman E, et al. Myocardial infarction redefined–a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol. 2000;36:959–969.
   PubMed Web of Science ®Google Scholar
• Thygesen K, Alpert JS, White HD, et al. Universal definition of myocardial infarction. Circulation. 2007;116:2634–2653.
   PubMed Web of Science ®Google Scholar
• Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. Eur Heart J. 2012;33:2551–2767.
   PubMed Web of Science ®Google Scholar
• Sandoval Y, Apple FS. The global need to define normality: the 99th percentile value of cardiac troponin. Clin Chem. 2014;60:455–462.
   PubMed Web of Science ®Google Scholar
• Apple FS, Sandoval Y, Jaffe AS, et al. Cardiac troponin assays: guide to understanding analytical characteristics and their impact on clinical care. Clin Chem. 2017;63:73–81.
   PubMed Web of Science ®Google Scholar
• Apple FS, Quist HE, Doyle PJ, et al. Plasma 99th percentile reference limits for cardiac troponin and creatine kinase MB mass for use with European Society of Cardiology/American College of Cardiology consensus recommendations. Clin Chem. 2003;49:1331–1336.
   PubMed Web of Science ®Google Scholar
• Apple FS, Ler R, Murakami MM. Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population. Clin Chem. 2012;58:1574–1581.
   PubMed Web of Science ®Google Scholar
• Saaby L, Poulsen TS, Hosbond S, et al. Classification of myocardial infarction: frequency and features of type 2 myocardial infarction. Am J Med. 2013;126:789–797.
   PubMed Web of Science ®Google Scholar
• Reiter M, Twerenbold R, Reichlin T, et al. Early diagnosis of acute myocardial infarction in the elderly using more sensitive cardiac troponin assays. Eur Heart J. 2011;32:1379–1389.
   PubMed Web of Science ®Google Scholar
• Roffi M, Patrono C, Collet JP, et al. 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2016;37:267–315.
   PubMed Web of Science ®Google Scholar
• Wallace TW, Abdullah SM, Drazner MH, et al. Prevalence and determinants of troponin T elevation in the general population. Circulation. 2006;113:1958–1965.
   PubMed Web of Science ®Google Scholar
• de Lemos JA, Drazner MH, Omland T, et al. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. J Am Med Assoc. 2010;304:2503–2512.
   PubMed Web of Science ®Google Scholar
• deFilippi CR, de Lemos JA, Christenson RH, et al. Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults. J Am Med Assoc. 2010;304:2494–2502.
   PubMed Web of Science ®Google Scholar
• Koerbin G, Tate JR, Hickman PE. Analytical characteristics of the Roche highly sensitive troponin T assay and its application to a cardio-healthy population. Ann Clin Biochem. 2010;47:524–528.
   PubMed Web of Science ®Google Scholar
• Eggers KM, Lind L, Ahlstrom H, et al. Prevalence and pathophysiological mechanisms of elevated cardiac troponin I levels in a population-based sample of elderly subjects. Eur Heart J. 2008;29:2252–2258.
   PubMed Web of Science ®Google Scholar
• Hammarsten O, Fu ML, Sigurjonsdottir R, et al. Troponin T percentiles from a random population sample, emergency room patients and patients with myocardial infarction. Clin Chem. 2012;58:628–637.
   PubMed Web of Science ®Google Scholar
• Dallmeier D, Denkinger M, Peter R, et al. Sex-specific associations of established and emergent cardiac biomarkers with all-cause mortality in older adults: the actiFE study. Clin Chem. 2015;61:389–399.
   PubMed Web of Science ®Google Scholar
• Shah AS, Griffiths M, Lee KK, et al. High sensitivity cardiac troponin and the under-diagnosis of myocardial infarction in women: prospective cohort study. BMJ. 2015;21:1–9.
   Google Scholar
• Mueller-Hennessen M, Lindahl B, Giannitsis E, et al. Diagnostic and prognostic implications using age- and gender-specific cut-offs for high-sensitivity cardiac troponin T. Sub-analysis from the TRAPID-AMI study. Int J Cardiol. 2016;209:26–33.
   PubMed Web of Science ®Google Scholar
• Saran R, Li Y, Robinson B, et al. US Renal Data System 2015 annual data report: epidemiology of kidney disease in the United States. Am J Kidney Dis. 2016;67:A7–A8.
   Web of Science ®Google Scholar
• Freda BJ, Tang WH, Van Lente F, et al. Cardiac troponins in renal insufficiency: review and clinical implications. J Am Coll Cardiol. 2002;40:2065–2071.
   PubMed Web of Science ®Google Scholar
• Kanderian AS, Francis GS. Cardiac troponins and chronic kidney disease. Kidney Int. 2006;69:1112–1114.
   PubMed Web of Science ®Google Scholar
• Stacy SR, Suarez-Cuervo C, Berger Z, et al. Role of troponin in patients with chronic kidney disease and suspected acute coronary syndrome: a systematic review. Ann Intern Med. 2014;161:502–512.
   PubMed Web of Science ®Google Scholar
• Apple FS, Murakami MM, Pearce LA, et al. Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease. Circulation. 2002;106:2941–2945.
   PubMed Web of Science ®Google Scholar
• Dubin RF, Li Y, He J, et al. Predictors of high sensitivity cardiac troponin T in chronic kidney disease patients: a cross-sectional study in the chronic renal insufficiency cohort (CRIC). BMC Nephrol. 2013;14:229.
   PubMed Web of Science ®Google Scholar
• Bansal N, Hyre Anderson A, Yang W, et al. High-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide (NT-proBNP) and risk of incident heart failure in patients with CKD: the Chronic Renal Insufficiency Cohort (CRIC) study. J Am Soc Nephrol. 2015;26:946–956.
   PubMed Web of Science ®Google Scholar
• Twerenbold R, Wildi K, Jaeger C, et al. Optimal cutoff levels of more sensitive cardiac troponin assays for the early diagnosis of myocardial infarction in patients with renal dysfunction. Circulation. 2015;131:2041–2050.
   PubMed Web of Science ®Google Scholar
• IFCC Task Force on Clinical Applications of Cardiac Bio-Markers (TF-CB). 2017. Available from: http://www.ifcc.org/executive-board-and-council/eb-task-forces/task-force-on-clinical-applications-of-cardiac-bio-markers-tf-cb
   Google Scholar
• Apple FS. A new season for cardiac troponin assays: it’s time to keep a scorecard. Clin Chem. 2009;55:1303–1306.
   PubMed Web of Science ®Google Scholar
• Jaffe AS, Apple FS, Morrow DA, et al. Being rational about (im)precision: a statement from the Biochemistry Subcommittee of the Joint European Society of Cardiology/American College of Cardiology Foundation/American Heart Association/World Heart Federation Task Force for the definition of myocardial infarction. Clin Chem. 2010;56:941–943.
   PubMed Web of Science ®Google Scholar
• Christenson RH, Jacobs E, Uettwiller-Geiger D, et al. Comparison of 13 commercially available cardiac troponin assays in a multicenter North-American study. J Appl Lab Med. 2017;1:544–561.
   Google Scholar
• Tate JR, Bunk DM, Christenson RH, et al. Evaluation of standardization capability of current cardiac troponin I assays by a correlation study: results of an IFCC pilot project. Clin Chem Lab Med. 2015;53:677–690.
   PubMed Web of Science ®Google Scholar
• Apple FS, Collinson PO, IFCC Task Force on Clinical Applications of Cardiac Biomarkers. Analytical characteristics of high-sensitivity cardiac troponin assays. Clin Chem. 2012;58:54–61.
   PubMed Web of Science ®Google Scholar
• Cardiac troponin I Booklet. HyTest Ltd. 2017. Available from: https://www.hytest.fi
   Google Scholar
• Pretorius CJ, Dimeski G, O'Rourke PK, et al. Outliers as a cause of false cardiac troponin results: investigating the robustness of 4 contemporary assays. Clin Chem. 2011;57:710–718.
   PubMed Web of Science ®Google Scholar
• Florkowski C, Wallace J, Walmsley T, et al. The effect of hemolysis on current troponin assays: a confounding preanalytical variable? Clin Chem. 2010;56:1995–1997.
   Web of Science ®Google Scholar
• Eriksson S, Hellman J, Petterson K. Autoantibodies against cardiac troponins. N Engl J Med. 2005;352:98–100.
   PubMed Web of Science ®Google Scholar
• Vylegzhanina AV, Kogan AE, Katrukha IA, et al. Anti-cardiac troponin autoantibodies are specific to the conformational epitopes formed by cardiac troponin I and troponin T in the ternary troponin complex. Clin Chem. 2017;63:343–350.
   PubMed Web of Science ®Google Scholar
• Warner JV, Marshall GA. High incidence of macrotroponin I with a high-sensitivity troponin I assay. Clin Chem Lab Med. 2016;54:1821–1829.
   PubMed Web of Science ®Google Scholar
• Kavsak P, Roy C, Malinowski P, et al. Macrocomplexes and discordant high-sensitivity cardiac troponin concentrations. Ann Clin Biochem. 2017;4563217734883. [cited 2017 Jan 1]. DOI:10.1177/0004563217734883
   Google Scholar
• Septh M, Seibold K, Katz N. Interaction between heparin and cardiac troponin T and troponin I from patients after coronary bypass surgery. Clin Biochem. 2002;35:355–362.
   PubMed Web of Science ®Google Scholar
• Simons J, Beach L, Clark L, et al. Matrix and bilirubin interference for high-sensitivity cardiac troponin I. Clin Chim Acta. 2015;442:49–51.
   PubMed Web of Science ®Google Scholar
• Krintus M, Kozinski M, Boudry P, et al. European multicenter analytical evaluation of the Abbott ARCHITECT STAT high sensitive troponin I immunoassay. Clin Chem Lab Med. 2014;52:1657–1665.
   PubMed Web of Science ®Google Scholar
• Koerbin G, Abhayaratna WP, Potter JM, et al. Effect of population selection on 99th percentile values for a high sensitivity cardiac troponin I and T assays. Clin Biochem. 2013;46:1636–1643.
   PubMed Web of Science ®Google Scholar
• Collinson PO, Heung YM, Gaze D, et al. Influence of population selection on the 99th percentile reference value for cardiac troponin assays. Clin Chem. 2012;58:219–225.
   PubMed Web of Science ®Google Scholar
• Giannitsis E, Kurz K, Hallermayer K, et al. Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem. 2010;56:254–261.
   PubMed Web of Science ®Google Scholar
• Thygesen K, Mair J, Katus H, et al. Recommendations for the use of cardiac troponin measurement in acute cardiac care. Eur Heart J. 2010;31:2197–2204.
   PubMed Web of Science ®Google Scholar
• Hickman PE, Badrick T, Wilson SR, et al. Reporting of cardiac troponin - problems with the 99th population percentile. Clin Chim Acta. 2007;381:182–183.
   PubMed Web of Science ®Google Scholar
• Apple FS, Jaffe AS, Collinson P, et al. IFCC educational materials on selected analytical and clinical applications of high sensitivity cardiac troponin assays. Clin Biochem. 2015;48:201–203.
   PubMed Web of Science ®Google Scholar
• Eggers KM, Apple FS, Lind L, et al. The applied statistical approach highly influences the 99th percentile of cardiac troponin I. Clin Biochem. 2016;49:1109–1112.
   PubMed Web of Science ®Google Scholar
• Thygesen K, Mair J, Giannitis E, et al. How to use high-sensitivity cardiac troponins in acute cardiac care. Eur Heart J. 2012;33:2252–2257.
   PubMed Web of Science ®Google Scholar
• Fraser CG. Interpretation of differences in serial troponin results. 2016. Available from: https://www.westgard.com/troponin-interpretations.htm
   Google Scholar
• Eggers KM, Jaffe AS, Venge P, et al. Clinical implications of the change of cardiac troponin I levels in patients with acute chest pain: an evaluation with respect to the universal definition of myocardial infarction. Clin Chim Acta. 2011;41:291–297.
   Google Scholar
• Ricos C, Cava F, Garcia-Lario JV, et al. The reference change value: a proposal to interpret laboratory reports in serial testing based on biological variation. Scand J Clin Lab Invest. 2004;64:175–184.
   PubMed Web of Science ®Google Scholar
• Wu AH, Lu QA, Todd J, et al. Short- and long-term biological variation in cardiac troponin I measured with a high-sensitivity assay: implications for clinical practice. Clin Chem. 2009;55:52–58.
   PubMed Web of Science ®Google Scholar
• Frankenstein L, Wu AH, Hallermayer K, et al. Biological variation and reference change value of high-sensitivity troponin T in healthy individuals during short and intermediate follow-up periods. Clin Chem. 2011;57:1068–1071.
   PubMed Web of Science ®Google Scholar
• Kozinski M, Krintus M, Kubica J, et al. High-sensitivity cardiac troponin assays: from improved analytical performance to enhanced risk stratification. Crit Rev Clin Lab Sci. 2017;54:143–172.
   PubMed Web of Science ®Google Scholar
• Mueller Biener M, Vafaie M, Doerr S, et al. Absolute and relative kinetic changes of high-sensitivity cardiac troponin T in acute coronary syndrome and in patients with increased troponin in the absence of acute coronary syndrome. Clin Chem. 2012;58:209–218.
   PubMed Web of Science ®Google Scholar
• Reichlin T, Irfan A, Twerenbold R, et al. Utility of absolute and relative changes in cardiac troponin concentrations in the early diagnosis of acute myocardial infarction. Circulation. 2011;124:136–145.
   PubMed Web of Science ®Google Scholar
• Alpert JS, Thygesen KA, White HD, et al. Diagnostic and therapeutic implications of type 2 myocardial infarction: review and commentary. Am J Med. 2014;127:105–108.
   PubMed Web of Science ®Google Scholar
• Collinson P, Lindahl B. Type-2 myocardial infarction: the chimaera of cardiology? Heart. 2015;101:1697–1703.
   PubMed Web of Science ®Google Scholar
• Sandoval Y, Thygesen K. Myocardial infarction type 2 and myocardial Injury. Clin Chem. 2017;63:101–107.
   PubMed Web of Science ®Google Scholar
• Smith SW, Diercks DB, Nagurney JT, et al. Central versus local adjudication of myocardial infarction in a cardiac biomarker trial. Am Heart J. 2013;165:273–279.
   PubMed Web of Science ®Google Scholar
• Díaz-Garzon J, Sandoval Y, Smith SW, et al. Discordance between ICD-coded myocardial infarction and diagnosis according to the Universal Definition of Myocardial Infarction. Clin Chem. 2017;63:415–419.
   PubMed Web of Science ®Google Scholar
• Santalo M, Martin A, Velilla J, et al. Using high-sensitivity troponin T: the importance of the proper gold standard. Am J Med. 2013;126:709–717.
   PubMed Web of Science ®Google Scholar
• Wildi K, Gimenez MR, Twerenbold R, et al. Misdiagnosis of myocardial infarction related to limitations of the current regulatory approach to define clinical decision values for cardiac troponin. Circulation. 2015;131:2032–2040.
   PubMed Web of Science ®Google Scholar
• Ng SM, Krishnaswamy P, Morrisey R, et al. Mitigation of the clinical significance of spurious elevations of cardiac troponin I in settings of coronary ischemia using serial testing of multiple cardiac markers. Am J Cardiol. 2001;87:994–999.
   PubMed Web of Science ®Google Scholar
• Giannitsis E, Katus HA. Cardiac troponin level elevations not related to acute coronary syndromes. Nat Rev Cardiol. 2013;10:623–634.
   PubMed Web of Science ®Google Scholar
• Jaffe AS, Ordonez-Llanos J. High-sensitivity cardiac troponin: from theory to clinical practice. Rev Esp Cardiol (Engl Ed). 2013;66:687–691.
   PubMed Web of Science ®Google Scholar
• Bandstein N, Ljung R, Johansson M, et al. Undetectable high-sensitivity cardiac troponin T level in the emergency department and risk of myocardial infarction. J Am Coll Cardiol. 2014;63:2569–2578.
   PubMed Web of Science ®Google Scholar
• Rubini-Gimenez M, Hoeller R, Reichlin T, et al. Rapid rule out of acute myocardial infarction using undetectable levels of high-sensitivity cardiac troponin. Int J Cardiol. 2013;168:3896–3901.
   PubMedGoogle Scholar
• Pickering JW, Than MP, Cullen L, et al. Rapid rule-out of acute myocardial infarction with a single high-sensitivity cardiac troponin T measurement below the limit of detection: a collaborative meta-analysis. Ann Intern Med. 2017;166:715–724.
   PubMed Web of Science ®Google Scholar
• Body R, Reynard C. One shot to rule out: does the limit of detection of a high-sensitivity troponin assay hit the mark? Clin Chem. 2017;63:21–23.
   PubMed Web of Science ®Google Scholar
• Lyon AW, Kavsak PA, Lyon OA, et al. Simulation models of misclassification error for single thresholds of high-sensitivity cardiac troponin I due to assay bias and imprecision. Clin Chem. 2017;63:585–592.
   PubMed Web of Science ®Google Scholar
• Boeddinghaus J, Nestelberger T, Twerenbold R, et al. Direct comparison of 4 very early rule-out strategies for acute myocardial infarction using high-sensitivity cardiac troponin I. Circulation. 2017;135:1597–1611.
   PubMed Web of Science ®Google Scholar
• Than M, Herbert M, Flaws D, et al. What is an acceptable risk of major adverse cardiac event in chest pain patients soon after discharge from the Emergency Department?: a clinical survey. Int J Cardiol. 2013;166:752–754.
   PubMed Web of Science ®Google Scholar
• Reichlin T, Schindler C, Drexler B, et al. One-hour rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T. Arch Intern Med. 2012;172:1211–1218.
   PubMedGoogle Scholar
• Reichlin T, Twerenbold R, Wildi K, et al. Prospective validation of a 1-hour algorithm to rule-out and rule-in acute myocardial infarction using a high sensitivity cardiac troponin T assay. Can Med Assoc J. 2015;187:E243–E252.
   PubMed Web of Science ®Google Scholar
• Mueller C, Giannitsis E, Christ M, et al. Multicenter evaluation of a 0-hour/1-hour algorithm in the diagnosis of myocardial infarction with high-sensitivity cardiac troponin T. Ann Emerg Med. 2016;68:76–87.
   PubMed Web of Science ®Google Scholar
• Pickering JW, Greenslade JH, Cullen L, et al. Assessment of the European Society of Cardiology 0-hour/1-hour algorithm to rule-out and rule-in acute myocardial infarction. Circulation. 2016;134:1532–1541.
   PubMed Web of Science ®Google Scholar
• Rubini Gimenez M, Twerenbold R, Jaeger C, et al. One-hour rule-in and rule-out of acute myocardial infarction using high-sensitivity cardiac troponin I. Am J Med. 2015;128:861–870.
   PubMed Web of Science ®Google Scholar
• Kavsak PA, Don-Wauchope AC, Hill SA, et al. Acceptable analytical variation may exceed high-sensitivity cardiac troponin I cutoffs in early rule-out and rule-in acute myocardial infarction algorithms. Clin Chem. 2016;62:887–889.
   PubMed Web of Science ®Google Scholar
• Crea F, Jaffe AS, Collinson PO, et al. Should the 1h algorithm for rule in and rule out of acute myocardial infarction be used universally? Eur Heart J. 2016;37:3316–3323.
   PubMedGoogle Scholar
• Wildi K, Nelles B, Twerenbold R, et al. Safety and efficacy of the 0 h/3 h protocol for rapid rule out of myocardial infarction. Am Heart J. 2016;181:16–25.
   PubMed Web of Science ®Google Scholar
• Pickering JW, Greenslade JH, Cullen L, et al. Validation of presentation and 3 h high-sensitivity troponin to rule-in and rule-out acute myocardial infarction. Heart. 2016;102:1270–1278.
   PubMed Web of Science ®Google Scholar
• Chapman AR, Anand A, Boeddinghaus J, et al. Comparison of the efficacy and safety of early rule-out pathways for acute myocardial infarction. Circulation. 2017;135:1586–1596.
   PubMed Web of Science ®Google Scholar
• Than M, Cullen L, Reid CM, et al. A 2-h diagnostic protocol to assess patients with chest pain symptoms in the Asia-Pacific region (ASPECT): a prospective observational validation study. Lancet. 2011;377:1077–1084.
   PubMed Web of Science ®Google Scholar
• Cullen L, Mueller C, Parsonage WA, et al. Validation of high-sensitivity troponin I in a 2-hour diagnostic strategy to assess 30-day outcomes in emergency department patients with possible acute coronary syndrome. J Am Coll Cardiol. 2013;62:1242–1249.
   PubMed Web of Science ®Google Scholar
• McCord J, Cabrera R, Lindahl B, et al. Prognostic utility of a modified HEART score in chest pain patients in the Emergency Department. Circ Cardiovasc Qual Outcomes. 2017;10:1–8.
   Web of Science ®Google Scholar
• Mokhtari A, Borna C, Gilje P, et al. A 1-h combination algorithm allows fast rule-out and rule-in of major adverse cardiac events. J Am Coll Cardiol. 2016;67:1531–1540.
   PubMed Web of Science ®Google Scholar
• Aldous SJ. Cardiac biomarkers in acute myocardial infarction. Int J Cardiol. 2013;164:282–294.
   PubMed Web of Science ®Google Scholar
• Lipinski MJ, Escarcega RO, D'Ascenzo F, et al. A systematic review and collaborative meta-analysis to determine the incremental value of copeptin for rapid rule-out of acute myocardial infarction. Am J Cardiol. 2014;113:1581–1591.
   PubMed Web of Science ®Google Scholar
• Raskovalova T, Twerenbold R, Collinson PO, et al. Diagnostic accuracy of combined cardiac troponin and copeptin assessment for early rule-out of myocardial infarction: a systematic review and meta-analysis. Eur Heart J Acute Cardiovasc Care. 2014;3:18–27.
   PubMedGoogle Scholar
• Mueller C, Möckel M, Giannitsis E, et al. Use of copeptin for rapid rule-out of acute myocardial infarction. Eur Heart J Acute Cardiovasc Care. 2017;2048872617710791. [cited 2017 Jun 1]. DOI:10.1177/2048872617710791
   Google Scholar